FDA: Does Not Intend to Take Action Against Compounders for Violations of FD&C Act Arising From Conditions That Depend on Tirzepatide Injection
FDA:不打算对因依赖于Tirzepatide注射的条件而违反FD&C法案的复合药剂师采取行动
FDA: Does Not Intend to Take Action Against Compounders for Violations of FD&C Act Arising From Conditions That Depend on Tirzepatide Injection
FDA:不打算对因依赖于Tirzepatide注射的条件而违反FD&C法案的复合药剂师采取行动
使用浏览器的分享功能,分享给你的好友吧